These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 39192415

  • 1. [Clinical Characteristics and Prognosis of Myelodysplastic Syndromes Patients with RUNX1 Gene Mutation].
    Chen Y, Ji YR, Zhang JY, Qin WW, Liu CC, Liu L, Yan XQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1173-1180. PubMed ID: 39192415
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical characteristics and prognosis of patients with myelodysplastic syndrome with a bone marrow nucleated erythroid cell proportion of greater than or equal to 50].
    Zeng YP, Li B, Qin TJ, Xu ZF, Qu SJ, Pan LJ, Gao QY, Jiao M, Wu JY, Wang HJ, Li CW, Ja YJ, Sun Q, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul 14; 45(7):651-659. PubMed ID: 39231769
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysis.
    He W, Zhao C, Hu H.
    Hematology; 2020 Dec 14; 25(1):494-501. PubMed ID: 33317419
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].
    Zhang WW, Zhang YL, Ren CC, Wu TK, Liu B.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb 14; 32(1):176-183. PubMed ID: 38387918
    [Abstract] [Full Text] [Related]

  • 8. [Clinical features and prognostic factors of advanced myelodysplastic syndromes in children].
    Liu CM, Chen YL, Wang XC, Li XL, An WB, Wan Y, Ren YY, Chen X, Liu F, Guo Y, Chen XJ, Zhang L, Zou Y, Chen YM, Li J, Guo XJ, Zhu XF, Yang WY.
    Zhonghua Yi Xue Za Zhi; 2024 Jul 16; 104(27):2529-2534. PubMed ID: 38978377
    [Abstract] [Full Text] [Related]

  • 9. RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome.
    Chen CY, Lin LI, Tang JL, Ko BS, Tsay W, Chou WC, Yao M, Wu SJ, Tseng MH, Tien HF.
    Br J Haematol; 2007 Nov 16; 139(3):405-14. PubMed ID: 17910630
    [Abstract] [Full Text] [Related]

  • 10. Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information.
    Tefferi A, Gangat N, Mudireddy M, Lasho TL, Finke C, Begna KH, Elliott MA, Al-Kali A, Litzow MR, Hook CC, Wolanskyj AP, Hogan WJ, Patnaik MM, Pardanani A, Zblewski DL, He R, Viswanatha D, Hanson CA, Ketterling RP, Tang JL, Chou WC, Lin CC, Tsai CH, Tien HF, Hou HA.
    Mayo Clin Proc; 2018 Oct 16; 93(10):1363-1374. PubMed ID: 29866419
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of RUNX1 Gene Mutation in Patients with Myelodysplastic Syndrome].
    Cai XH, Chen MY, Chao HY, Jiang NK, Lu XZ, Han WM, Qin W, Jia ZX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb 16; 28(1):202-208. PubMed ID: 32027277
    [Abstract] [Full Text] [Related]

  • 12. Co-mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome.
    Ren Y, Lang W, Mei C, Luo Y, Ye L, Wang L, Zhou X, Xu G, Ma L, Jin J, Tong H.
    Hematol Oncol; 2023 Feb 16; 41(1):159-166. PubMed ID: 36316121
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes.
    Zhang L, Chen K, Li Y, Chen Q, Shi W, Ji T, Tao H, He Z, Wang C, Yu L.
    Hematology; 2023 Dec 16; 28(1):2181773. PubMed ID: 36892252
    [Abstract] [Full Text] [Related]

  • 14. Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.
    Jiang L, Luo Y, Zhu S, Wang L, Ma L, Zhang H, Shen C, Yang W, Ren Y, Zhou X, Mei C, Ye L, Xu W, Yang H, Lu C, Jin J, Tong H.
    Cancer Sci; 2020 Feb 16; 111(2):580-591. PubMed ID: 31804030
    [Abstract] [Full Text] [Related]

  • 15. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
    Zhang HX, Pang AM, Chen X, Zhang RL, Zhai WH, Ma QL, Yang DL, Wei JL, He Y, Feng SZ, Han MZ, Jiang EL.
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct 14; 42(10):814-822. PubMed ID: 34788920
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between clinical characteristics and myelodysplastic syndrome patients with isocitrate dehydrogenase gene mutations].
    Tong HY, Hu C, Yu MX, Ma QL, Chen FF, Ye L, Wei JY, Xu GX, Mao LP, Li Y, Jin J.
    Zhonghua Yi Xue Za Zhi; 2013 Oct 29; 93(40):3180-4. PubMed ID: 24405536
    [Abstract] [Full Text] [Related]

  • 17. SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome.
    Falantes JF, Márquez-Malaver FJ, Carrillo E, Culebras MG, Morales R, Prats C, Vargas MT, Caballero T, Rodríguez-Arbolí E, Espigado I, Pérez-Simón JA.
    Clin Lymphoma Myeloma Leuk; 2022 Dec 29; 22(12):e1059-e1066. PubMed ID: 36117041
    [Abstract] [Full Text] [Related]

  • 18. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).
    Yao CY, Hou HA, Lin TY, Lin CC, Chou WC, Tseng MH, Chiang YC, Liu MC, Liu CW, Kuo YY, Wu SJ, Liao XW, Lin CT, Ko BS, Chen CY, Hsu SC, Li CC, Huang SY, Yao M, Tang JL, Tsay W, Liu CY, Tien HF.
    Oncotarget; 2016 Sep 27; 7(39):63177-63188. PubMed ID: 27527853
    [Abstract] [Full Text] [Related]

  • 19. [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome].
    Zhao WS, Zhang YT, Jiang QL, Liu QF, Dai M.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec 27; 28(6):1977-1984. PubMed ID: 33283729
    [Abstract] [Full Text] [Related]

  • 20. [Clinical Characteristics of Acute Myeloid Leukemia Patients with RUNX1 Gene Mutation].
    Ni ZF, Ma LJ, Shi LL, Shen PL, Zhao JQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct 27; 29(5):1411-1416. PubMed ID: 34627418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.